nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—TNF—narcolepsy	0.88	1	CbGaD
Clenbuterol—NGF—autonomic nervous system—narcolepsy	0.0347	0.698	CbGeAlD
Clenbuterol—NGF—forebrain—narcolepsy	0.00808	0.163	CbGeAlD
Clenbuterol—NGF—brain—narcolepsy	0.00335	0.0675	CbGeAlD
Clenbuterol—ADRB3—Amine ligand-binding receptors—HRH3—narcolepsy	0.00213	0.0304	CbGpPWpGaD
Clenbuterol—ADRB1—forebrain—narcolepsy	0.0021	0.0424	CbGeAlD
Clenbuterol—TNF—Monoamine Transport—HRH3—narcolepsy	0.00183	0.0261	CbGpPWpGaD
Clenbuterol—ADRB3—G alpha (s) signalling events—P2RY11—narcolepsy	0.00156	0.0222	CbGpPWpGaD
Clenbuterol—TNF—TNF receptor signaling pathway —TNFRSF1B—narcolepsy	0.00127	0.0182	CbGpPWpGaD
Clenbuterol—ADRB1—Amine ligand-binding receptors—HRH3—narcolepsy	0.00127	0.0181	CbGpPWpGaD
Clenbuterol—ADRB3—Monoamine GPCRs—HTR2A—narcolepsy	0.00126	0.018	CbGpPWpGaD
Clenbuterol—ADRB2—Amine ligand-binding receptors—HRH3—narcolepsy	0.00124	0.0177	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.00117	0.0167	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Other—P2RY11—narcolepsy	0.00116	0.0165	CbGpPWpGaD
Clenbuterol—ADRB3—Amine ligand-binding receptors—HTR2A—narcolepsy	0.00106	0.0152	CbGpPWpGaD
Clenbuterol—TNF—Cytokines and Inflammatory Response—HLA-DRB1—narcolepsy	0.000951	0.0136	CbGpPWpGaD
Clenbuterol—ADRB1—G alpha (s) signalling events—P2RY11—narcolepsy	0.000924	0.0132	CbGpPWpGaD
Clenbuterol—ADRB2—G alpha (s) signalling events—P2RY11—narcolepsy	0.000904	0.0129	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000897	0.0128	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000897	0.0128	CbGpPWpGaD
Clenbuterol—ADRB1—brain—narcolepsy	0.000873	0.0176	CbGeAlD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000866	0.0124	CbGpPWpGaD
Clenbuterol—TNF—Apoptosis—TNFRSF1B—narcolepsy	0.000786	0.0112	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000769	0.011	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000769	0.011	CbGpPWpGaD
Clenbuterol—ADRB1—Monoamine GPCRs—HTR2A—narcolepsy	0.000751	0.0107	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000742	0.0106	CbGpPWpGaD
Clenbuterol—ADRB2—Monoamine GPCRs—HTR2A—narcolepsy	0.000734	0.0105	CbGpPWpGaD
Clenbuterol—TNF—TNF alpha Signaling Pathway—TNFRSF1B—narcolepsy	0.000731	0.0104	CbGpPWpGaD
Clenbuterol—ADRB3—G alpha (s) signalling events—NPS—narcolepsy	0.000729	0.0104	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000705	0.0101	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000631	0.00901	CbGpPWpGaD
Clenbuterol—ADRB1—Amine ligand-binding receptors—HTR2A—narcolepsy	0.000631	0.009	CbGpPWpGaD
Clenbuterol—ADRB2—Amine ligand-binding receptors—HTR2A—narcolepsy	0.000617	0.00881	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—HCRTR1—narcolepsy	0.000585	0.00835	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—HCRTR2—narcolepsy	0.000585	0.00835	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—HLA-DQA1—narcolepsy	0.000566	0.00808	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—P2RY11—narcolepsy	0.000565	0.00807	CbGpPWpGaD
Clenbuterol—CYP1A1—brain—narcolepsy	0.000563	0.0113	CbGeAlD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000563	0.00803	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000532	0.0076	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000532	0.0076	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—HLA-DQB1—narcolepsy	0.00053	0.00756	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR2—narcolepsy	0.000521	0.00743	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—HCRTR1—narcolepsy	0.000521	0.00743	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000514	0.00734	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—P2RY11—narcolepsy	0.000503	0.00718	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.00049	0.00699	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—HCRT—narcolepsy	0.000481	0.00686	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000478	0.00682	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000456	0.00651	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000456	0.00651	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR1—narcolepsy	0.000446	0.00637	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRTR2—narcolepsy	0.000446	0.00637	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000441	0.00629	CbGpPWpGaD
Clenbuterol—ADRB1—G alpha (s) signalling events—NPS—narcolepsy	0.000433	0.00617	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—P2RY11—narcolepsy	0.000431	0.00615	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—PENK—narcolepsy	0.000428	0.00611	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—TAC1—narcolepsy	0.000427	0.00609	CbGpPWpGaD
Clenbuterol—ADRB2—G alpha (s) signalling events—NPS—narcolepsy	0.000423	0.00604	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000419	0.00598	CbGpPWpGaD
Clenbuterol—TNF—Allograft Rejection—HLA-DRB1—narcolepsy	0.000403	0.00575	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000375	0.00535	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HCRT—narcolepsy	0.000366	0.00523	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—TRH—narcolepsy	0.000364	0.0052	CbGpPWpGaD
Clenbuterol—CYP1A1—Fatty acid, triacylglycerol, and ketone body metabolism—CPT1B—narcolepsy	0.000357	0.00509	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000348	0.00496	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000348	0.00496	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—HCRTR2—narcolepsy	0.000347	0.00496	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—HCRTR1—narcolepsy	0.000347	0.00496	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HCRTR2—narcolepsy	0.000343	0.00489	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HCRTR1—narcolepsy	0.000343	0.00489	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—HCRTR2—narcolepsy	0.00034	0.00485	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—HCRTR1—narcolepsy	0.00034	0.00485	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—P2RY11—narcolepsy	0.000336	0.00479	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000334	0.00476	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—P2RY11—narcolepsy	0.000331	0.00473	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—HCRTR2—narcolepsy	0.000331	0.00472	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—HCRTR1—narcolepsy	0.000331	0.00472	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—P2RY11—narcolepsy	0.000328	0.00468	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—PENK—narcolepsy	0.000327	0.00466	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Other—HTR2A—narcolepsy	0.000326	0.00465	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—P2RY11—narcolepsy	0.000319	0.00456	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—HRH3—narcolepsy	0.000319	0.00456	CbGpPWpGaD
Clenbuterol—NGF—SIDS Susceptibility Pathways—TNF—narcolepsy	0.000303	0.00433	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HCRTR2—narcolepsy	0.0003	0.00429	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HCRTR1—narcolepsy	0.0003	0.00429	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000291	0.00415	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—P2RY11—narcolepsy	0.00029	0.00414	CbGpPWpGaD
Clenbuterol—NGF—MAPK Signaling Pathway—TNF—narcolepsy	0.000286	0.00408	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—HCRT—narcolepsy	0.000285	0.00407	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—HRH3—narcolepsy	0.000284	0.00406	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000284	0.00405	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HCRT—narcolepsy	0.000282	0.00402	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—HCRT—narcolepsy	0.000279	0.00398	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TRH—narcolepsy	0.000278	0.00396	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—HCRT—narcolepsy	0.000272	0.00388	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—TAC1—narcolepsy	0.000265	0.00378	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—NPS—narcolepsy	0.000265	0.00378	CbGpPWpGaD
Clenbuterol—TNF—SIDS Susceptibility Pathways—HTR2A—narcolepsy	0.000257	0.00366	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—PENK—narcolepsy	0.000254	0.00363	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PENK—narcolepsy	0.000251	0.00358	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000249	0.00355	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—PENK—narcolepsy	0.000249	0.00355	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HCRT—narcolepsy	0.000247	0.00352	CbGpPWpGaD
Clenbuterol—ADRB3—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000244	0.00348	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HRH3—narcolepsy	0.000244	0.00347	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—PENK—narcolepsy	0.000242	0.00345	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PENK—narcolepsy	0.00022	0.00314	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—TRH—narcolepsy	0.000216	0.00308	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TRH—narcolepsy	0.000213	0.00305	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—TRH—narcolepsy	0.000211	0.00302	CbGpPWpGaD
Clenbuterol—ADRB3—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000209	0.00298	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000209	0.00298	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000206	0.00294	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000206	0.00294	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—TRH—narcolepsy	0.000206	0.00294	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—NPS—narcolepsy	0.000202	0.00288	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—TAC1—narcolepsy	0.000202	0.00288	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—HCRTR2—narcolepsy	0.000196	0.0028	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—HCRTR1—narcolepsy	0.000196	0.0028	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—HCRTR1—narcolepsy	0.000192	0.00274	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—HCRTR2—narcolepsy	0.000192	0.00274	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—P2RY11—narcolepsy	0.00019	0.00271	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—HRH3—narcolepsy	0.00019	0.0027	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HRH3—narcolepsy	0.000187	0.00267	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—TRH—narcolepsy	0.000187	0.00267	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—P2RY11—narcolepsy	0.000185	0.00265	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—HRH3—narcolepsy	0.000185	0.00265	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—HRH3—narcolepsy	0.000181	0.00258	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HCRTR2—narcolepsy	0.000178	0.00254	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HCRTR1—narcolepsy	0.000178	0.00254	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HCRTR2—narcolepsy	0.000177	0.00253	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HCRTR1—narcolepsy	0.000177	0.00253	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HCRTR1—narcolepsy	0.000174	0.00249	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HCRTR2—narcolepsy	0.000174	0.00249	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—P2RY11—narcolepsy	0.000172	0.00246	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—P2RY11—narcolepsy	0.000171	0.00245	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—P2RY11—narcolepsy	0.000168	0.0024	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HRH3—narcolepsy	0.000164	0.00234	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—HCRT—narcolepsy	0.000161	0.0023	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000161	0.0023	CbGpPWpGaD
Clenbuterol—CYP1A1—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000161	0.0023	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR ligand binding—HTR2A—narcolepsy	0.000159	0.00227	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—HCRT—narcolepsy	0.000158	0.00225	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—TAC1—narcolepsy	0.000157	0.00224	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—NPS—narcolepsy	0.000157	0.00224	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—TAC1—narcolepsy	0.000155	0.00221	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—NPS—narcolepsy	0.000155	0.00221	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—TAC1—narcolepsy	0.000154	0.00219	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—NPS—narcolepsy	0.000154	0.00219	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—TAC1—narcolepsy	0.00015	0.00213	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—NPS—narcolepsy	0.00015	0.00213	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HCRT—narcolepsy	0.000146	0.00209	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HCRT—narcolepsy	0.000146	0.00208	CbGpPWpGaD
Clenbuterol—ADRB1—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000145	0.00207	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PENK—narcolepsy	0.000144	0.00205	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HCRT—narcolepsy	0.000143	0.00204	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	0.000142	0.00203	CbGpPWpGaD
Clenbuterol—ADRB2—GPCRs, Class A Rhodopsin-like—HTR2A—narcolepsy	0.000142	0.00202	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PENK—narcolepsy	0.000141	0.00201	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—TAC1—narcolepsy	0.000136	0.00194	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—NPS—narcolepsy	0.000136	0.00194	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CHKB—narcolepsy	0.000133	0.0019	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PENK—narcolepsy	0.00013	0.00186	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PENK—narcolepsy	0.00013	0.00185	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PENK—narcolepsy	0.000128	0.00182	CbGpPWpGaD
Clenbuterol—ADRB1—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000124	0.00177	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—TRH—narcolepsy	0.000122	0.00174	CbGpPWpGaD
Clenbuterol—ADRB2—Class A/1 (Rhodopsin-like receptors)—HTR2A—narcolepsy	0.000121	0.00173	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—TRH—narcolepsy	0.00012	0.00171	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—TRH—narcolepsy	0.000111	0.00158	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TRH—narcolepsy	0.00011	0.00158	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—TRH—narcolepsy	0.000109	0.00155	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—HRH3—narcolepsy	0.000107	0.00153	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HCRTR2—narcolepsy	0.000105	0.0015	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HCRTR1—narcolepsy	0.000105	0.0015	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—HRH3—narcolepsy	0.000105	0.0015	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HCRTR1—narcolepsy	0.000103	0.00147	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HCRTR2—narcolepsy	0.000103	0.00147	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—narcolepsy	0.000103	0.00147	CbGpPWpGaD
Clenbuterol—CYP1A2—Aryl Hydrocarbon Receptor—TNF—narcolepsy	0.000103	0.00147	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—P2RY11—narcolepsy	0.000102	0.00145	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—P2RY11—narcolepsy	9.95e-05	0.00142	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HRH3—narcolepsy	9.73e-05	0.00139	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HRH3—narcolepsy	9.68e-05	0.00138	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HRH3—narcolepsy	9.52e-05	0.00136	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR ligand binding—HTR2A—narcolepsy	9.45e-05	0.00135	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HTR2A—narcolepsy	9.33e-05	0.00133	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CHKB—narcolepsy	9.31e-05	0.00133	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—HTR2A—narcolepsy	9.24e-05	0.00132	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CPT1B—narcolepsy	9.06e-05	0.00129	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—HTR2A—narcolepsy	9e-05	0.00128	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—NPS—narcolepsy	8.88e-05	0.00127	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—TAC1—narcolepsy	8.88e-05	0.00127	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—NPS—narcolepsy	8.68e-05	0.00124	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—TAC1—narcolepsy	8.68e-05	0.00124	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HCRT—narcolepsy	8.65e-05	0.00123	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HCRT—narcolepsy	8.46e-05	0.00121	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HTR2A—narcolepsy	8.17e-05	0.00117	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—NPS—narcolepsy	8.06e-05	0.00115	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—TAC1—narcolepsy	8.06e-05	0.00115	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TAC1—narcolepsy	8.02e-05	0.00114	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—NPS—narcolepsy	8.02e-05	0.00114	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—NPS—narcolepsy	7.89e-05	0.00113	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—TAC1—narcolepsy	7.89e-05	0.00113	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PENK—narcolepsy	7.71e-05	0.0011	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PENK—narcolepsy	7.54e-05	0.00108	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TRH—narcolepsy	6.55e-05	0.000935	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TRH—narcolepsy	6.41e-05	0.000915	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CPT1B—narcolepsy	6.33e-05	0.000903	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CHKB—narcolepsy	5.94e-05	0.000847	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HRH3—narcolepsy	5.75e-05	0.00082	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HRH3—narcolepsy	5.62e-05	0.000802	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—HTR2A—narcolepsy	5.34e-05	0.000762	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—HTR2A—narcolepsy	5.22e-05	0.000745	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HTR2A—narcolepsy	4.85e-05	0.000692	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HTR2A—narcolepsy	4.83e-05	0.000689	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NPS—narcolepsy	4.76e-05	0.000679	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TAC1—narcolepsy	4.76e-05	0.000679	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HTR2A—narcolepsy	4.74e-05	0.000677	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TAC1—narcolepsy	4.66e-05	0.000665	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NPS—narcolepsy	4.66e-05	0.000665	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CPT1B—narcolepsy	4.04e-05	0.000576	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR2A—narcolepsy	2.86e-05	0.000409	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR2A—narcolepsy	2.8e-05	0.0004	CbGpPWpGaD
